共 50 条
- [41] The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's DiseaseCURRENT ALZHEIMER RESEARCH, 2016, 13 (09) : 985 - 995Magistri, MarcoVelmeshev, DmitryMakhmutova, MadinaPatel, PruthaSartor, Gregory C.Volmar, Claude-HenryWahlestedt, ClaesFaghihi, Mohammad Ali
- [42] BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell linesArchives of Dermatological Research, 2017, 309 : 491 - 497Hiroaki KamijoMakoto SugayaNaomi TakahashiTomonori OkaTomomitsu MiyagakiYoshihide AsanoShinichi Sato
- [43] BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell linesARCHIVES OF DERMATOLOGICAL RESEARCH, 2017, 309 (06) : 491 - 497Kamijo, HiroakiSugaya, MakotoTakahashi, NaomiOka, TomonoriMiyagaki, TomomitsuAsano, YoshihideSato, Shinichi
- [44] Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor ScaffoldsJOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (02) : 504 - 513Chan, Kwok-HoZengerle, MichaelTesta, AndreaCiulli, Alessio
- [45] The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibitionONCOTARGET, 2015, 6 (33) : 34669 - 34679Yao, WeilongYue, PingKhuri, Fadlo R.Sun, Shi-Yong
- [46] The BET bromodomain inhibitor JQ1 synergizes with WEE1 inhibitor AZD1775 by impairing non-homologous end joining and enhancing DNA damages in non-small cell lung cancerCANCER RESEARCH, 2018, 78 (13)Takashima, YutaKikuchi, EikiKikuchi, JunkoShoji, TetsuakiFuruta, MegumiKikuchi, HajimeSakakibara-Konishi, JunKinoshita, IchiroDosaka-Akita, HirotoshiNishimura, Masaharu
- [47] Development and validation of an LC-MS/MS method to quantify the bromodomain and extra-terminal (BET) inhibitor JQ1 in mouse plasma and brain microdialysate: Application to cerebral microdialysis studyJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 204Nair, SreenathDavis, AbigailCampagne, OliviaSchuetz, John D.Stewart, Clinton F.
- [48] MYC inhibition in human malignancy by BET-Bromodomain inhibitor JQ1, using a 3-D human tumor primary culture micro-spheroid platform to explore clinically relevant observationsCANCER RESEARCH, 2017, 77Nagourney, Robert AlanEvans, Steven S.Nagourney, Alexander J.Bernard, Paula J.Francisco, Federico R.Sheth, MilanVora, NileshDeo, Eknath
- [49] The BET-Bromodomain Inhibitor JQ1 synergized ABT-263 against colorectal cancer cells through suppressing c-Myc-induced miR-1271-5p expressionBIOMEDICINE & PHARMACOTHERAPY, 2017, 95 : 1574 - 1579Wu, ZhenqianHu, ZedongHan, XiaodongLi, ZhongnanZhu, QingchaoWang, YuZheng, QiYan, Jun
- [50] Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain InhibitorJOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (20) : 8369 - 8384McDaniel, Keith F.Wang, LeSoltwedel, ToddFidanze, Steven D.Hasvold, Lisa A.Liu, DachunMantei, Robert A.Pratt, John K.Sheppard, George S.Bui, Mai H.Faivre, Emily J.Huang, XiaoliLi, LeimingLin, XiaoyuWang, RongqiWarder, Scott E.Wilcox, DeniseAlbert, Daniel H.Magoc, Terrance J.Rajaraman, GaneshPark, Chang H.Hutchins, Charles W.Shen, Jianwei J.Edalji, Rohinton P.Sun, Chaohong C.Martin, RuthGao, WenqingWong, ShekmanFang, GuoweiElmore, Steven W.Shen, YuKati, Warren M.